Clinical Trial Update: Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Xeomin, Radiesse, and Belotero for facial/neck rejuvenation targeting photoaging; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging

Drugs mentioned

• Belotero (hyaluronic acid dermal filler)
• Radiesse (Calcium hydroxylapatite)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Main Line Center for Laser Surgery | Conditions: Photoaging | Phase 4 | Status: COMPLETED